At the annual «Green Cross» award, which recognizes the best achievements in the pharmaceutical industry, Solopharm won two prestigious awards in two nominations:
- Atrevozol® was recognized as «Drug #1 for Anxiety and Stress».
- Solosorb received the «Pharmacists' Choice: Enterosorbents for Adults and Children» award.
The «Green Cross» award is one of the most authoritative industry competitions, where winners are determined by pharmaceutical market professionals and healthcare experts. The awards received confirm that Solopharm products are in demand among both specialists and consumers, and meet high standards of quality and effectiveness.
«For us, these awards are not just recognition of our brands. They confirm that we are moving in the right direction: creating solutions that help doctors and pharmacists work with greater confidence, and patients feel better and live full lives. Each of our products is the result of in-depth research, an innovative approach, and a desire to improve people's health here and now», noted the Solopharm press center.
Solopharm thanks patients, medical specialists, and partners for their trust and support. Winning the «Green Cross» award is an impetus for further development, expansion of the product portfolio, and the introduction of new technologies that will make quality treatment even more accessible.
Media Contacts:
Solopharm Press Service
